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In Latin American, there is currently a regional action with the main purposes of putting the concept of severe
neonatal morbidity in practice and formulating proposals for interventions. A general overview of neonatal
health conditions, including morbidity and mortality, is provided to update regional knowledge on the topic. An
example of the development and implementation of the concept of maternal near miss is also provided, followed
by results from a systematic review covering all previously published studies on Neonatal Near Miss. Finally, some
proposals for building a common concept on the topic and for launching a prospective surveillance study are
presented. A Neonatal Near Miss is a neonate who had a severe morbidity (organ dysfunction or failure) but who
survived this condition within the first 27 days of life. The pragmatic criteria recommended to be used are as
follows: birth weight below 1700 g, Apgar score below 7 at 5 minutes of life and gestational age below 33 weeks.
As a proxy for organ dysfunction, the following management criteria are also confirmed: parenteral therapeutic
antibiotics; nasal continuous positive airway pressure; any intubation during the first 27 days of life; phototherapy
within the first 24 h of life; cardiopulmonary resuscitation; the use of vasoactive drugs, anticonvulsants,
surfactants, blood products and steroids for refractory hypoglycemia and any surgical procedure. Although this
study starts from a regional perspective, this topic is clearly globally relevant. All nations, especially low and
middle-income countries, could benefit from the proposed standardization.
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’ INTRODUCTION
The Latin American Center of Perinatology (CLAP, Mon-
tevideo, Uruguay) from the Pan American Health Organization
(PAHO, Washington, DC), with the support from several
countries from the region, is currently leading an action with
the objectives of filling gaps in knowledge about severe
neonatal morbidity and joining expertise on the topic to
formulate proposals for interventions, considering that neonatal
mortality is currently responsible for approximately 60% of
infant mortality in the region. These objectives could contribute
to the effort to achieve Millennium Development Goals 4 and 5
until 2015, namely to reduce infant mortality and improve
maternal health, respectively (1).
For this purpose, a general overview on neonatal health
conditions, including both morbidity and mortality, is
necessary to update regional knowledge of the topic. This
update should be followed by a round of discussions and
proposals with the final aim of building a consensual concept
of Neonatal Near Miss. In addition, an environment allowing
the performance of a prospective surveillance pilot study in
which all Latin American countries can participate is to be
created. Although the study starts from a regional perspec-
tive, this topic is clearly globally relevant. All nations,
especially low- and middle-income countries, could benefit
from this standardization.
Neonatal Near Miss as a tool for reducing neonatal
morbidity and mortality in Latin America and the
‘‘Stork Network’’ in Brazil
From 1990 to 2012, infant mortality decreased by 77% in
Brazil (2-4). In 2013, the country achieved goal 4 of theDOI: 10.6061/clinics/2015(12)10
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Millennium Development Goals by improving infant health
conditions in association with public policies and health care
programs such as the Unified Health Care System (Sistema
Único de Saúde - SUS), thereby augmenting primary health
care, the Family Health Program, immunization policies,
national maternal breastfeeding policy, Child-Friendly Hos-
pital, Breastfeed Brazil, Milk Bank network and Family Fund
Program. This decrease in Brazilian infant mortality was
most significant in the poorest regions of the country. Brazil
has focused on equity, with the premise that more should be
offered to those in greater need, i.e., the north and northeast
of the country. Infant mortality rates in these regions are
currently close to those in the southeast region, which is the
richest in the country (2).
Neonatal mortality in Brazil corresponds to 70% of the total
rate of infant mortality; neonatal mortality has reduced more
slowly than that of other age groups and has become a major
health challenge for the country. The main causes of neonatal
mortality in Brazil are prematurity, congenital malformations,
perinatal infections and perinatal asphyxia (3). The country has
a neonatal resuscitation program supported by the Ministry of
Health and coordinated by the Brazilian Society of Pediatrics.
A government regulation was designed to ensure that a health
professional that is qualified in neonatal resuscitation is in
every place of childbirth.
Currently, the perinatal paradox in Brazil is that the causes
of high maternal and neonatal mortality rates are preven-
table with health care actions. In contrast, childbirth has been
intensely medicalized, with 98% due to hospitals and 88%
due to doctors (2,3). Millennium Development Goal 5 will
likely not be achieved by 2015; despite a decrease in maternal
mortality, the achievement of this goal remains a challenge.
Decreasing the current caesarean rate in the country, which is
52%, also represents a major challenge. Despite a significant
reduction in infant mortality, it remains elevated in specific
populations such as Indians, quilombolas (escaped slaves),
riverside populations and others.
The Brazilian Project, named the Stork Network, is aimed
at reducing infant and maternal mortality (5,6). Although
major technological advances have been made in Brazil, no
evidence-based practices have been fully adopted in Obste-
trics and Neonatology; thus, unnecessary childbirth and
neonatal interventions and the vulgarization of caesarean
sections occur. The aims of the Stork Network are to ensure a
woman’s right to pregnancy, prenatal care, humane and safe
childbirth and postpartum care as well as the newborn
infant’s right to safe and humane birth and care. In addition,
investment has been made in infant development such as in
the Tender Brazil Program and programs existing in Chile,
Colombia and Cuba. The Stork Network acts in the prenatal,
childbirth and postpartum phases, in family planning and in
infant care until 2 years of age via making information
available, mobilizing society, creating committees and
investing in collective spaces. Other aims of the network
are greater autonomy for the woman in labor, vulnerability
and risk assessment, risk classification, educational practices
and action by the obstetric nurse in a multiprofessional team.
The network ensures that laboratory tests are conducted at
the appropriate time, links basic care to maternity hospitals
and informs the mothers of the place of childbirth. The
network aims to increase the number of neonatal beds,
mainly in those regions in greater need, investing in the
Kangaroo Method to capacitate professionals. Furthermore,
promoting the presence of the father from prenatal care to
birth and postpartum period follow-up and creating child-
birth centers with obstetric nurses to perform deliveries and
pregnant mother-baby house are other aims.
From 2009 to 2011, Brazil made advances in a surveillance
method for maternal and infant deaths with a rigid protocol
for notification, investigation and recording. This method
may help in the implementation of any action involving
Neonatal Near Miss.
Neonatal Health in Latin America and the
Caribbean: problems and challenges
In the region of the Americas, there are 15.6 million births
annually. Of these births, 94% are assisted by skilled health
professionals. Of the total number of births, 200 thousand
infants die before the first year of life, and 125 thousand
infants die in the first 28 days of life, accounting for neonatal
deaths (3,4).
Between 1990 and 2010, neonatal mortality decreased by
approximately 50%. However, neonatal mortality was the
component that decreased the least among children under
5 years of age. Neonatal mortality contributed 43% in 1990
and 50% in 2010 to the mortality rate in those under 5 years
of age (7,8).
In an analysis of neonatal mortality, from 60 to 70% of infant
deaths occurred before 7 days of life. Additionally, participation
of the neonatal component in mortality varied widely in those
under 5 years of age in different countries in the Americas.
Mortality in those under 5 ranged fromo 10 to 100 deaths per
thousand live-born infants among American countries. This
great variation also occurred in different regions within each
country. Prematurity (35%), neonatal asphyxia (15%) and
infections (12%) represent the main causes of death in Latin
America and the Caribbean, accounting for 3/4 of all the causes
of neonatal mortality. These percentages are similar in all the
regions of the Americas and are important markers of neonatal
mortality and morbidity not only after birth but also in prenatal
and perinatal care (4,9).
Annually, approximately 1.2 million newborn infants weigh
o2500 g at birth and approximately 1.2 million are premature.
The majority of newborn infants, almost 1 million, are born
between 33-36 weeks; 80 thousand are premature infants born
under 28 weeks. The extremely premature infants have the
greatest risks and are fewer in number. However, the
remaining premature infants are also at risk.
Approximately 1 million newborn infants in the Americas
require some maneuver at birth. Resuscitation maneuvers are
dependent on the quality level of the health facility. Procedures
involved in resuscitation range from aspiration, oxygenation
and intubation up to admission to the neonatal intensive care
unit (ICU). The mortality risk is 5- to 20-fold higher in pre-
mature infants, with short-term risks of neurological alterations,
thermal dysregulation and metabolic dysregulation. Some may
present visual and hearing alterations, chronic pulmonary
disease, and neurological deficits with medium to long-term
consequences in quality of life; there may also be a family and a
social impact. Retinopathy is a consequence of prematurity, the
quality of perinatal care and the use of oxygen. The prevalence
of retinopathy in newborn infants in the region ranges from
20 to 30% in those with a birth weight o1500 g, meaning that
1 in every 3 very low birth weight infants has a risk of
retinopathy. This aspect is important to address in the quality of
care (10), as the prevalence of blindness due to prematurity
retinopathy ranges from 13% to 60% in the region (11).
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Late preterm infants represent an average number of
1 million infants born in the region. There is a 1.2- to 3-fold
higher risk of some morbidity, respiratory difficulty, jaundice
and the need for endovenous fluids, antibiotics and certain
interventions in infants born at 37-38 weeks compared with
infants born at 39 weeks. From a health management
perspective, this reflects on increased health care costs. The
cost of preterm infant care is estimated to be approximately
US$ 10 million per year.
In 2008, the PAHO/CLAP developed a strategy and
regional action plan for newborn health in the context of a
continuous process of maternal, newborn and infant care,
considering that the neonatal component had insufficient
visibility in the political agenda. Specific action plans to
address the neonatal topic and disaggregated data remained
limitations. It was only possible to work with national mean
values. Furthermore, the quality of care was impaired in the
implementation of evidence-based interventions and limited
access to health care was available (12).
The action plan was created with the purpose of providing
countries of the region with support to achieve the
Millennium Development Goals, highlighting the interven-
tions to be implemented in perinatal health care, guided by
4 strategic areas: 1) create a favorable environment for the
promotion of neonatal health; 2) strengthen health care
systems and improve access to health care services for
women, newborn infants and children; 3) promote commu-
nity interventions; 4) create and strengthen systems for the
surveillance, monitoring and classification of specific topics
linked to the newborn infant (12).
After 5 years since the approval of this regional action plan,
a medium-term analysis showed that 9 in every 10 countries
have a national plan for maternal and neonatal health care.
However, only 57.1% have a specific budget for neonatal care
and 82% of the countries have strategic alliances; such alliances
were considered important or very important. Regarding
access to quality health care, 99% of births are assisted by
skilled professionals in more than half of the countries and this
number is lower than 90% in 20% of the countries. However, in
some geographical areas, coverage is lower than 50% and even
lower than 10%. The norms, guidelines and protocols are
already available, but their implementation is often limited
and may vary from 40% to 100% (9).
Countries also have information systems with varied and
often limited coverage and reach; 88.5% have health systems
that evaluate vital signs, 77% have health information
systems (SIP/CLAP) and 70% have surveillance systems of
mortality. Health information systems are less common at the
community level (50%).
Based on these limitations and difficulties, focus should be
directed toward development of the neonatal health compo-
nent, as follows: 1) short-term: maintain efforts to reduce
neonatal mortality and intervene in the main causes of
preventable death, especially prematurity; 2) medium-term:
address topics that contribute to a reduction in morbimor-
tality and that affect quality of life, such as prematurity,
metabolic conditions, development and growth, to improve
quality of life; 3) and long-term: strengthen community
experiences or interventions that produce optimal results.
These strategies are developed with technical cooperation
from countries and through the generation of evidence, the
formulation of guidelines and capacitation.
The strategy approach is to focus on the priority aspects
associated with morbidity and mortality, to strengthen health
services, to work on the capacitation of human resources
and to articulate with other groups contributing to experi-
ence for technical development. With the knowledge of
neonatal mortality, new challenges may be discussed, seek-
ing a surveillance system of severe neonatal conditions that
require decision-making in the search for better results in
neonatal care.
Development of the concept of Maternal Near Miss
as an example
Understanding of the development process of the concept
and criteria of Maternal Near Miss may help in the
development of Neonatal Near Miss. In 2009, the definition
of Maternal Near Miss (MNM) was published. Women
suffering a severe complication during pregnancy, childbirth
or within 42 days of the postpartum period, at risk of death,
but survived by chance or due to effective interventions were
considered maternal near miss (13).
The original idea, in the context of a public policy, was to
strengthen health quality through a surveillance system by
which severe maternal morbidity could be identified through
hospital and mortality information systems. The aim was to
create an online system for identifying severe morbidity cases,
raising an alert and treating the case as priority, initiating a
series of interventions at the location or transferring the
patient to a place where adequate care could be given.
A systematic review was the first step in the development
of Maternal Near Miss in Brazil and worldwide (14,15). Few
studies had previously been published on the concept. In the
second half of the decade of 2000, the study sought optimal
criteria for severe maternal morbidity based on the Mantel
criteria (South Africa), which were fundamental dysfunc-
tions of organs and systems and the Waterstone criteria
(England) using clinical criteria and combined criteria
(16,17). None of the criteria alone were sufficiently specific
to define a population at risk.
Questionnaires that were validated and used in the research
on the World Health Organization (WHO) Global Survey
were applied to construct a pragmatic definition of Maternal
Near Miss. The pragmatic criteria used were retrospective
because they were easily collected. The management criteria
and organ dysfunctions were based on case management. The
most common criteria in Maternal Near Miss cases were
hysterectomy, admission to the ICU, blood transfusion,
cardiac or renal complication and eclampsia. In subsequent
studies, cardiac or renal complications were not confirmed.
The pragmatic criteria established by the WHO are currently
hysterectomy, admission to the ICU, blood transfusion and
eclampsia (18).
Due to the diversity of criteria for Maternal Near Miss,
women were interviewed by population surveys to provide
information about the occurrence of any severe complica-
tions. The criteria for severe maternal morbidity were tested
in a questionnaire answered by women through a module
introduced in the Brazilian National Demography Health
Survey (PNDS) on maternal morbidity. The pragmatic criteria
defined by the WHO were tested, finding 21 cases /1,000
live births (LB), the first estimate of the occurrence of
Maternal Near Miss in the Brazilian population. The results
were published, confirming the criteria for eclampsia,
hysterectomy, admission to the ICU and blood transfusion,
which together determined effectively the total number of
maternal deaths (19).
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Severity scores were tested and those addressing dysfunc-
tion or failure showed optimal results. Criteria concerning
the organ systems were used. These criteria were elaborated
in such a manner that they could be identified in different
settings, both in tertiary services that have laboratory
markers available and in primary services, along with
corresponding clinical dysfunctions. The idea was to produce
a system that could be used prospectively, including a group
of clinical situations that could potentially define a threat to
life. A checklist would be used for this purpose, to observe a
group of other variables that would also indicate a threat to
life in a more specific manner. Therefore, Near Miss is always
a retrospective diagnosis and cases of death are similar; the
only difference is the actual outcome, which occurs by
chance or by an effective intervention.
In developing the WHO criteria, the Sequential Organ
Failure Assessment (SOFA) was tested between 2002 and
2006 in all women with potentially life-threatening condi-
tions from a Brazilian maternity. The study showed that
SOFA performed better among organ failure and death. This
pre-validation of the criteria for organ dysfunction showed
highly satisfactory results (20). Therefore, the WHO also
included these dysfunction criteria. In 2009, there was a
publication on the definition and criteria of Maternal Near
Miss established by the WHO (13).
After the criteria were tested, the WHO recommended that
the approach to identify Maternal Near Miss, with several
indicators constructed from surveillance, should qualify the
type of health care provided. In Brazil, a national surveillance
network for severe maternal morbidity was constructed,
including 27 centers. During one year, a prospective surveil-
lance of all criteria for potentially life-threatening conditions
was conducted (21). This surveillance generated a maternal
severity index for transforming collected data into scores,
allowing the quality of obstetric care to be assessed. This index
was used in the study of the WHO Multicountry Survey that
included over 300 thousand cases to identify the quality of
obstetric care in three continents (22). A delay in seeking and
reaching the facility was frequently observed, as was a delay
in receiving the adequate type of care. Delays were directly
associated with outcome severity and occurred in 52% of
potentially life-threatening conditions, in 68% of Maternal
Near Miss cases and in 84% of maternal deaths, indicating the
accountability of hospital managers and health care profes-
sionals (23).
Systematic Review on Neonatal Near Miss
Analogous to Maternal Near Miss, the proposed definition
of Neonatal Near Miss would be a newborn infant who
nearly died but who survived a complication occurring
during pregnancy, during childbirth, or in the first 7 days
after the termination of pregnancy. The criteria to be used
should be simple, highly correlated with death, sufficiently
rare and homogeneous for mortality risk in each case.
A Neonatal Near Miss case should be strikingly similar to a
death case because the two are similar, except for the
outcome. The Neonatal Near Miss criteria were also based on
the identification of markers of organ dysfunction, including
laboratory, management and clinical criteria, and on inter-
ventions associated with the management of severity.
A systematic review was performed following the Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines for systematic reviews (24).
Three electronic databases were consulted: EMBASE, PubMed
and SciELO. The keyword ‘‘Neonatal Near Miss’’ was used.
The search syntax was as follows: ‘‘(neonatal morbidity) AND
(neonatal illness severity score) OR (neonatal diseases severity
score) AND (neonatal mortality)’’. No restrictions on time or
language were used and all types of studies were accepted.
One hundred and eight (108) articles were initially found in
these electronic databases. Duplicate articles, irrelevant titles
and full-text articles containing no original Neonatal Near
Miss data were excluded. Four articles were selected for
review (25).
The first study, entitled ‘‘Neonatal Near Miss: a measure of
the quality of obstetric care’’, was published in 2009. In this
study, data from ‘‘Saving Babies: 2003-2005: Fifth Perinatal
Care Survey of South Africa’’ were used (26). For criteria to
define Neonatal Near Miss, markers of dysfunction and/or
organ failure were used, showing an infant mortality rate of
6.3/1,000 LB and a Neonatal Near Miss rate of 24.7/1,000 LB.
The majority of Neonatal Near Miss cases were of dysfunc-
tion/respiratory failure (63%), followed by dysfunction/
immunologic failure, including infections (21.2%), and by
dysfunction/central nervous system failure (5%). Compared
with neonatal deaths, more cases of Neonatal Near Miss
were observed in obstetric patients in whom asphyxia,
trauma or antepartum hemorrhage had occurred. According
to these data, many morbidity cases are lost when only
neonatal mortality cases are evaluated.
The second study, ‘‘Neonatal Near Miss approach in the
2005 WHO Global Survey Brazil’’, was published in 2010.
After cleaning the database, 15,169 cases were used. In this
study, a secondary analysis with the Brazilian component of
the ‘‘2005 WHO Global Survey on Maternal and Perinatal
Health’’ database was performed (27). A definition of
Neonatal Near Miss was developed based on the main
causes of death: prematurity and perinatal asphyxia. The
conditions associated with a risk of Neonatal Near Miss were
very low birth weight (o1500 g), a gestational age younger
than 30 weeks at birth and an Apgar score lower than 7 at 5
minutes of life. The early neonatal mortality rate was 8.2/
1,000 LB and the Neonatal Near Miss rate was 21.4/1,000 LB.
The rate of early neonatal mortality was estimated by the
percentage of deaths in the first week of life among
newborns at risk during delivery (27.7%). The severe
neonatal outcome rate, which was 29.5/1,000 LB, was
calculated by the sum of the number of deaths and the
number of Near Miss cases. In this study, 121 death cases
were observed; 80% of these cases had some of the selected
conditions. Diagnostic evaluation was the adopted approach:
the Near Miss criteria were considered diagnostic tests for
mortality prediction. With these criteria (gestational ageo30
weeks, very low birth weight or Apgaro7 at the fifth minute
of life), the sensitivity was 82%, the specificity was 97%, and
almost all of the cases had information available in medical
charts. Comparing the different services revealed that
Neonatal Near Miss could also be used to evaluate the
quality of perinatal care.
The third study was published in 2014 with the title
‘‘Development of criteria for identifying neonatal near-miss
cases: analyses of two WHO multicountry cross-sectional
studies’’. Secondary analyses of the following two WHO
databases were performed: the ‘‘Global Survey on Maternal
and Perinatal Health’’ (WHOGS) and the ‘‘Multicountry
Survey on Maternal and Newborn Health’’ (WHOMCS).
In the first database, 277,706 cases were analyzed, revealing
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a mortality rate of 1.35%. In the second study, 309,644 cases
were analyzed, revealing a mortality rate of 1.08%. In the
Global Survey database, criteria showing homogeneity in
terms of the mortality risk were chosen and the optimum
combination of diagnostic accuracy was obtained with an
Apgar score o7 at 5 minutes, a gestational age o33 weeks
and a birth weight o1750 g. These criteria were validated
and had the same performance when applied to the
Multicountry Survey database. The total early neonatal
mortality rate was 7.4/1,000 LB and the Neonatal Near Miss
rate was 44.4/1,000 LB (28).
Adopting a different approach thanWHOGS, the WHOMCS
used specific data on the management of neonatal severe
morbidity in addition to the three previously mentioned
variables. The following markers of severity management were
based on interventions used in the South African study: the use
of intravenous antibiotics, the use of nasal continuous positive
airway pressure (CPAP) or intubation at any time in the first
week of life, cardiopulmonary resuscitation, the use of any
vasoactive drug, the use of phototherapy in the first 24 hours of
life, the use of anticonvulsants, the administration of a
surfactant, the use of blood transfusion, the use of corticoids
in refractory hypoglycemia, and any surgery in the first week of
life (29). The only stratifying variable used was the human
development index (HDI) from 2012.
In this study, countries with a moderate and low HDI
predominated. The pragmatic criteria alone showed a
sensitivity of 77%, a specificity of 96% and a diagnostic
odds ratio of 87. The management criteria showed a
sensitivity of 79%, a specificity of 94% and a diagnostic
odds ratio of 66. The combination of pragmatic criteria and
management criteria showed a better performance with a
sensitivity and specificity of almost 93% and a very good
diagnostic odds ratio of 163.
The total rate of early neonatal mortality was 9.2/1,000 LB
and the Neonatal Near Miss rate was 72.5/1,000 LB
considering any pragmatic or management marker. The
Neonatal Near Miss rate was 37.4/1,000 LB for pragmatic
markers and 53/1,000 LB for management markers. The
neonatal mortality index was 12.7% and the ratio of severe
neonatal outcome rate was 81.7/1,000 LB. Based on these
results, the optimal criteria for severe morbidity prediction
were intubation in the first week of life, cardiopulmonary
resuscitation and the use of vasoactive drugs. The case-
fatality relationship and the mortality index were also
evaluated, showing that countries with a high HDI had a
high case-fatality relationship and a low mortality index; the
opposite was observed for countries with a low HDI (28).
The fourth study, titled ‘‘Neonatal near miss in the Birth in
Brazil Survey’’, was published in 2014 using data from the
Born in Brazil Network. Nineteen variables were used:
Apgar o7 at 5 minutes of life, gestational age (p32, 33 to
36 and X37 weeks), birth weight (o1500, 1500 to 2499 and
X2500 grams), twinning, the use of mechanical ventilation,
the use of oxygen supplementation after birth, admission in
the neonatal intensive care unit (NICU), the use of nasal
CPAP, intubation in the delivery room, cardiac massage, the
use of resuscitation drugs, phototherapy in the first 72 hours
of life, the use of a surfactant, the use of antibiotics in the first
48 hours of life, congenital malformation, seizures, newborn
respiratory disease (transitory tachypnea, hyaline membrane
disease, pulmonary hypertension or meconium aspiration
syndrome), hypoglycemia and necrotizing enterocolitis. The
neonatal mortality rate was 11.1/1,000 LB and the Neonatal
Near Miss rate was 39.2/1,000 LB. Variables associated with
neonatal death were birth weight o1500 g, Apgar o7 at
5 minutes, the use of mechanical ventilation, premature
infant o32 gestational weeks and newborn infants with
congenital malformation (30).
Despite similarities between the criteria such as prematur-
ity and asphyxia chosen for each study, the criteria were not
the same because there remain no internationally accepted
definition and criteria. The neonatal period used in each
study ranged from 3 to 28 days after birth. All studies
analyzed showed that the Neonatal Near Miss rate was
higher than the neonatal mortality rate, increasing 2.6- to
eight-fold.
A systematic review is the first step in validating the
concept and identifying useful indicators to explore quality
of care, establishing priorities in the management of these
newborn infants, improving neonatal health care and thus
reducing the negative impact on the future lives of these
children. The criteria for defining the concept should be
simple, applicable in individual services and at the health
system level and significant for doctors, hospital adminis-
trators and health care professionals.
Criteria for identifying Neonatal Near Miss cases
developed from WHO studies
The proposal regarding Neonatal Near Miss is to seek an
instrument to evaluate the quality of perinatal care. The
proposal concerns not only with the neonatal period but with
also obstetric care and seeks to identify opportunities for
health improvement at the population level and possibilities
to assess more informative indicators than neonatal mortality.
The development of Neonatal Near Miss concept and criteria
may allow comparisons of the same institution over time and
of different institutions from different regions. Discussions of
morbidity are better accepted than death case reviews by health
care teams. Thus, the quality of care would improve. There is
an expectation of the development of prospective surveillance
processes of severe neonatal morbidity. The problem is that
until now, a large number of facilities, especially tertiary level
services use complex risk assessments that require laboratory
support such as SNAPPE and CRIB (31,32).
The Global Survey study was performed between 2004
and 2008, collecting hospital information on care provided
upon a woman’s admission until the newborn infant was
7 days old. Institutional clustering and multistage sampling
methods were used, with a probability proportional to the
population size. Each institution should perform at least
1,000 deliveries annually and have the capacity to perform
caesarean sections. These criteria are only met in more
complex services (18,28). Preliminary results of an ongoing
analysis of the WHO Multicountry Survey database guided
the selection of the proposed criteria for case definition.
There is concern regarding development of the concept of
Neonatal Near Miss and which direction that it should
follow. It could be restricted to neonatal care in the ICU, but
several previously validated and accepted scores are known
to be very useful for this purpose. Peripartum and
intrapartum care as well as the early neonatal repercussions
could also be assessed. Considering that the construction of
Neonatal Near Miss is to prevent death by effective
interventions, the role of extreme preterm and congenital
malformations should be more seriously discussed in this
context.
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A step forward: proposal for a common definition,
criteria, related health indicators and rationale for
a prospective surveillance system
The development of criteria and the definition of Neonatal
Near Miss are important for the subsequent creation of an
epidemiological surveillance system to be used as a tool for
public policy and case management. For this purpose,
criteria must be initially held on databases. However, a
comprehensive and prospective pilot study should be
subsequently conducted. The study may start with a sentinel
surveillance system in locations with a large number of
births using preexisting databases. Avalidation study should
be conducted to test whether the criteria may be generalized.
The data form the construction process and the application of
a pilot study to the Maternal Near Miss model performed by
CLAP is important to guide a similar procedure for the Neonatal
Near Miss condition. The Maternal Near Miss form includes
maternal data, clinical and laboratory criteria and interventions.
Data were collected by trained individuals and subsequently
crosschecked. Some health services could identify the problem
through the form. However, these services had no idea of what
to do with the information. The concept is that other locations
may monitor the occurrence of an event by using a computer-
ized system. Based on evidence of a problem, searching for
strategies and then performing the adequate evidence-based
intervention recommended for each situation is possible.
The definition of Neonatal Near Miss is ‘‘a newborn infant,
classified by severe morbidity (Near Miss) assessment
criteria, who survived these conditions within the first
27 days of life’’. For the identification of Neonatal Near
Miss, two groups of criteria were established based on the
results of previous studies on the topic. The first was formed
by the following pragmatic criteria defined:
 Birthweight o 1750 g
 Apgar score o7 at 5 minutes
 Gestational age o 33 complete weeks
The second group was characterized by the following
management criteria:
 Parenteral antibiotic therapy (up to 7 days and before
28 days of life)
 Nasal CPAP
 Any intubation up to 7 days and before 28 days of life
 Phototherapy within 24 hours of life
 Cardiopulmonary resuscitation
 Use of vasoactive drugs
 Use of anticonvulsants
 Use of surfactant
 Use of blood products
 Use of steroids for the treatment of refractory hypoglycemia
 Surgery
Some management variables were not analyzed in
previous studies; because these variables may be important
to characterize a Neonatal Near Miss case, they should be
tested in future studies:
 Use of antenatal steroid (categorize treatment regimens)
 Use of parenteral nutrition
 Identification of congenital malformation (classify types/
severity groups according to the International Classifica-
tion of Diseases, 10th revision – ICD-10)
 Apgar score at 5 minutes, if considered a Near Miss case by
another criterion
 Admission to the ICU
Although congenital malformation cases performed well
as severity markers in some studies, many of these death
cases may not have been preventable even with effective
interventions. Therefore, evaluating quality of care would
not be possible. The same situation should be questioned and
assessed regarding extremely premature infants.
Considering this concept and definition as well as the set
of criteria to be used for the identification of Neonatal Near
Miss, the corresponding health indicators with their respec-
tive definitions are as follows:
1. Early neonatal mortality rate (ENMR): refers to the death of
a live-born infant within the first 6 days of extrauterine
life/1,000 LB.
2. Neonatal mortality rate (NMR): refers to the death of a live-
born infant within the first 27 days of extrauterine life/
1,000 LB.
3. Neonatal Near Miss rate (NNMR): (number of Neonatal
Near Miss cases/total number of LB) X 1,000.
4. Early severe neonatal outcome rate (ESNOR): (number of
early neonatal deaths + number of early Neonatal Near
Miss cases/total number of LB) X 1,000.
5. Severe neonatal outcome rate (SNOR): (number of neonatal
deaths + number of Neonatal Near Miss cases/total
number of LB) X 1,000.
6. Case-fatality ratio: refers to the ratio between the number
of Neonatal Near Miss cases per neonatal death case.
A specific chart for data collection should be concomi-
tantly developed with the initial study protocol design. All
health facilities providing childbirth care in Latin America
and the Caribbean should participate in the study. The
selection of participating centers is to be performed by
countries in those regions, considering a representative
sample of all levels of care. Hopefully this article will trigger
a global rising interest in the topic and incur broader
participation of countries from all over the world in the
study, resulting in this concept and these criteria being used
as a true tool for improving the quality of health and life of
neonates worldwide.
PAHO Neonatal Near Miss Working Group
Argentina: Alejandro Jenik (Hospital Italiano de Buenos
Aires); Brazil: Antonio Moura da Silva (Federal University of
Maranhão, São Luis), Francisco Eulogio Martinez (Ribeirão
Preto Medical School, University of São Paulo), Joao
Henrique C. Leme de Almeida (Instituto Fernandes Figueira,
Fiocruz, Rio de Janeiro), José Simon Camelo Jr (Ribeirão
Preto Medical School, University of São Paulo), Oscar Suriel
(Pan American Health Organization, Brazil), Roseli Calil
(University of Campinas), Sergio Tadeu Martins Marba
(University of Campinas), Tatiana Raquel Selbmann Coimbra
(Brazilian Ministry of Health, Brasilia), Zeni Carvalho Lamy
(Federal University of Maranhão, São Luis); Colombia: Jorge
Mejia Lopez (Del Valle University, Cali); Peru: Marisol
Vicuña Olivera (Colectivo Neonatal, Lima); USA: Arnoldo
Grosman (University Maimonides, Washington), Goldy
Mazia (Latin American and Caribbean Neonatal Alliance);
Uruguay: Gerardo Martinez (CLAP, PAHO, Montevideo),
Magdalena Bonasso (CLAP, PAHO, Montevideo), Rodolfo
Gomez Ponce de Leon (CLAP, PAHO, Montevideo).
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